Professor John Turnidge AO[/caption]
FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
This educational activity was managed by PSA at the request of and with funding from GSK.[/caption]
Understanding and awareness
Topline information for shingles and RSV
Critical factors for pharmacy-led vaccination [for more information please refer to the PSA's Practice Guidelines for the provision of immunisation services]28
Natasha Dean (she/her) Protecting your over 60s from the flu
Get ready to help to protect vulnerable Australians over the age of 60 years from influenza and its most deadly complications.
Beyond sleep hygiene
Case scenario
Nia, 36 years old, presents to the pharmacy for advice, reporting difficulties falling asleep for the past 5 months. These problems started after...
Preparing for the 2024 ‘tripledemic’
Now is the time to arm Australians with vaccines, respiratory disease advice, testing and essential medicines to get ahead of respiratory ailment season.
The trifecta...
Exenatide for alcohol use disorder
A better understanding of exenatide can help increase our knowledge of GLP-1 analogues and their possible role in treating addiction.
Long-acting treatment for opioid dependence approved
The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA).
Buvidal Weekly and Buvidal Monthly...
Comorbid insomnia and sleep apnoea (COMISA)
Case scenario
Carmen, 54 years old, presents to the pharmacy reporting sleep difficulties.
She reports poor sleep quality and daytime exhaustion that started about 6 months...
